Immunotherapeutic molecules and uses thereof
AssigneeAravax Pty Ltd
InventorsROBYN O'HEHIR, JENNIFER ROLLAND, SARA PRICKETT
Life of this patent
Estimating the term…
Loading patent…
AssigneeAravax Pty Ltd
InventorsROBYN O'HEHIR, JENNIFER ROLLAND, SARA PRICKETT
Estimating the term…
The present invention relates generally to molecules such as peptides, polypeptides and proteins which interact immunologically with T lymphocytes in subjects having peanut allergy, or allergy to other tree nuts, and genetic sequences encoding same. These molecules are preferably immunointeractive with T cells in subjects having an allergy to the Ara H 1 allergen. The molecules of the present invention are useful in the development of diagnostic, therapeutic and prophylactic agents for conditions characterised by an aberrant, inappropriate or otherwise unwanted immune response to Ara h 1 or derivative or homologue thereof.
A vector comprising (i) one or more nucleic acid sequences encoding, or complementary to a nucleic acid sequence encoding, one or more peptides, each independently consisting of the amino acid sequence of any one of SEQ ID NOs:
Dependencies are inferred from the claim text.